BVMF/Z1BH34 (BVMF/Z1BH34)

Brazil Stock Exchange: BVMF/Z1BH34 · BRL

R$122

+0.00 (0.0%)· Recorded snapshot

Market cap	98.8B
Revenue (ttm)	44.1B
Net income (ttm)	4.2B
EPS (ttm)	R$5.53
P/E (trailing)	22.0x
P/E (forward)	11.1x
Dividend	R$0.80 (0.65%)
Volume	0
Beta	0.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 44.1B
Net income (ttm): 4.2B
EPS (ttm): R$5.53
P/E (trailing): 22.0x
P/E (forward): 11.1x
Market cap: 98.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E11.1

P25 n/aP50 n/aP75 n/a

Trailing P/E22

P25 n/aP50 n/aP75 n/a

ROE6.4

P25 n/aP50 n/aP75 n/a

ROIC6.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/Z1BH34 indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-04
Employees	17,000
Employees change	-1,000
Employees growth	-5.56%
Enterprise value	BRL 137.2B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1927
Industry	Medical Devices
Is primary listing	No
ISIN number	BRZ1BHBDR007
Last earnings date	2026-08-05
Last refreshed	2026-10-29
Market cap	BRL 98.8B
Next earnings date	2026-11-04
Price	BRL 121.50
Price currency	BRL
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-16
Symbol	bvmf/Z1BH34
Website	https://www.zimmerbiomet.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	62.14x
Average P/E ratio (3Y)	25.69x
Average P/E ratio (5Y)	47.28x
Earnings yield	4.55%
EV/Earnings	32.82x
EV/EBIT	18.02x
EV/EBITDA	9.86x
EV/FCF	22.06x
EV/Sales	3x
FCF / EV yield	4.53%
FCF yield	6.29%
Forward P/E	11.05x
Graham number	96.4898
Graham upside	-20.58%
Lynch fair value	BRL 25.70
Lynch upside	-78.85%
P/(FCF - SBC) ratio	17.3x
P/(OCF - SBC) ratio	11.59x
P/B ratio	1.51x
P/E ratio	21.97x
P/FCF ratio	15.89x
P/OCF ratio	10.94x
P/S ratio	2.24x
Price/EBITDA ratio	7.55x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.65%
EBITDA margin	29.68%
Effective tax rate	13.56%
FCF margin	13.6%
Gross margin	69.52%
Operating margin	16.65%
Pretax margin	10.97%
Profit margin	9.48%
Profit per employee	BRL 245,844
Profitable quarters	14
Profitable years	5
Revenue per employee	BRL 2.6M
ROA	3.88%
ROA (5Y)	3.96%
ROCE	7.16%
ROE	6.41%
ROE (5Y)	5.43%
ROIC	6.19%
ROIC (5Y)	6.45%
SBC / revenue	1.15%
Tax / revenue	1.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	0.17%
EPS growth (Q)	33.77%
EPS growth (QoQ)	-15.57%
EPS growth 10Y	14.16%
EPS growth 3Y	19.72%
EPS growth 5Y	-1.28%
EPS growth quarters	2
EPS growth years	0
FCF growth	-3.14%
FCF growth (Q)	24.48%
FCF growth (QoQ)	25.34%
FCF growth 3Y	14.96%
FCF growth 5Y	1.17%
Gross profit growth	6.05%
Gross profit growth (Q)	3.8%
Gross profit growth 3Y	4.66%
Gross profit growth 5Y	2.29%
Net income growth	-2.04%
Net income growth (Q)	29.78%
Net income growth (QoQ)	-16.72%
Net income growth 3Y	16.85%
Net income growth 5Y	-2.51%
Net income growth quarters	2
Net income growth years	0
OCF growth	4.83%
OCF growth (Q)	18.4%
OCF growth (QoQ)	24.6%
OCF growth 10Y	3.69%
OCF growth 3Y	8.88%
OCF growth 5Y	2.96%
Operating income growth	-8.28%
Operating income growth (Q)	-3.22%
Operating income growth 3Y	0.13%
Operating income growth 5Y	1.82%
Revenue growth	8.62%
Revenue growth (Q)	4.8%
Revenue growth (QoQ)	4.33%
Revenue growth 10Y	1.22%
Revenue growth 3Y	5.75%
Revenue growth 5Y	2.89%
Revenue growth quarters	15
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -2.8B
Depreciation and amortization	BRL 6B
EBIT	BRL 7.3B
EBITDA	BRL 13.1B
EPS	BRL 5.53
Financing cash flow	BRL -5.5B
Free cash flow	BRL 6.2B
Free cash flow minus SBC	BRL 5.7B
Gross profit	BRL 30.6B
Income taxes	BRL 655.9M
Investing cash flow	BRL -4.3B
Net borrowing	BRL -247.2M
Net cash flow	BRL -761.1M
Net income	BRL 4.2B
Operating cash flow minus SBC	BRL 8.5B
Operating income	BRL 7.3B
Revenue	BRL 44.1B
Stock-based compensation	BRL 508.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.51
Book value per share	BRL 343.14
Debt / EBITDA	2.94
Debt / equity	0.6
Debt / FCF	6.33
Goodwill	BRL 53.3B
Interest coverage	4.9
Long-term assets	BRL 90.7B
Long-term liabilities	BRL 36.5B
Net cash (debt)	BRL -37B
Net cash / market cap	-37.43%
Net debt / EBITDA	2.83
Net debt / equity	0.56
Net debt / FCF	5.95
Piotroski F-Score	6
Property, plant and equipment	BRL 12B
Shareholders' equity	BRL 65.4B
Tangible book value	BRL -9.1B
Tangible book value per share	BRL -47.76
Total assets	BRL 118.1B
Total cash	BRL 2.4B
Total debt	BRL 39.4B
Total liabilities	BRL 52.7B
WACC	5.88%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.37
Current assets	BRL 27.4B
Current liabilities	BRL 16.2B
Current ratio	1.69
Inventory turnover	1.1
Net working capital	BRL 14.6B
Quick ratio	0.74
Working capital	BRL 10.8B
Working capital turnover	19.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.95%
Dividend growth	-1.22%
Dividend growth (3Y)	-0.61%
Dividend growth (5Y)	-0.97%
Dividend growth years	0
Dividend payment date	2026-11-06
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.80
Dividend yield	0.65%
Ex-dividend date	2026-09-29
Last dividend	BRL 0.04
Payout ratio	23.35%
Shareholder yield	2.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	-3.02%
1M total return	-2.84%
1W price change	4.74%
1W total return	4.93%
20-day SMA	BRL 118.97
3M price change	8.81%
3M total return	9.21%
50-day SMA	BRL 136.67
52-week high	BRL 129.09
52-week high date	2026-09-02
52-week low	BRL 111.66
52-week low date	2026-06-22
5Y price change	-38.9%
5Y return CAGR	-8.84%
5Y total return	-37.06%
6M price change	1.35%
6M total return	1.72%
All-time high	BRL 231.40
All-time high date	2021-03-01
All-time low	BRL 100.00
All-time low date	2020-03-19
Average true range (ATR)	BRL 4.59
Average volume	36.8
Beta (5Y)	0.49
Change from 52-week high	-5.88%
Change from 52-week low	8.81%
Change from all-time high	-47.49%
Change from all-time low	21.5%
Change from open	0%
Day's gap	0%
High price	BRL 121.50
Low price	BRL 121.50
Monthly RSI	41.55
Open price	BRL 121.50
Previous close	BRL 121.50
Price vs 20-day SMA	2.13%
Price vs 50-day SMA	-11.1%
Relative volume	0.11
RSI	46.28
Sharpe ratio	0.11
Sortino ratio	0.28
Volume	0
Weekly RSI	43.85
YTD price change	-1.98%
YTD total return	-1.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	190.1M
Shares change (QoQ)	-1.53%
Shares change (YoY)	-1.95%
Shares held by insiders	0.18%
Shares held by institutions	106.08%
Short ratio	3.8 days

Deeper analysis on BVMF/Z1BH34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/Z1BH34 report

Is a complete BVMF/Z1BH34 research report available?

No complete published report is available for bvmf/Z1BH34 (BVMF/Z1BH34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/Z1BH34 (BVMF/Z1BH34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/Z1BH34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/Z1BH34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/Z1BH34

Frequently asked questions